Quick Answer
Candel Therapeutics, Inc. reported Long Term Debt of $560.0 thousand for the year ending 2021.
- Candel Therapeutics, Inc. showed an increase of +15.9% in Long Term Debt from 2020 to 2021.
- This data is from Candel Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 29, 2022.
- XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $521.0 thousand | Q3 2021: $541.0 thousand.
- Historical annual values: Fiscal year 2021: $560.0 thousand | Fiscal year 2020: $483.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: